Phil Nickson's Insider Trades & SAST Disclosures
Phil Nickson's most recent trade in Monte Rosa Therapeutics Inc was a trade of 161,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Phil Nickson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monte Rosa Therapeutics Inc | Phil Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 161,000 | 161,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Phil Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 36,000 | 36,000 | - | - | Common Stock | |
| Monte Rosa Therapeutics Inc | Phil Nickson | Chief Business & Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Nickson Philip | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 109,000 | 109,000 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Philip Nickson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 123,650 | 123,650 | - | - | Stock Option (Right to Buy) | |
| Monte Rosa Therapeutics Inc | Philip Nickson | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 70,600 | 70,600 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges